Table of Content

1 INTRODUCTION (Page No. - 27)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 IVD CONTRACT MANUFACTURING MARKET SEGMENTATION
                    FIGURE 2 IVD CONTRACT MANUFACTURING MARKET: REGIONAL SEGMENTATION
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
                    TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
    1.4 LIMITATIONS 
    1.5 STAKEHOLDERS 
2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END-USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: JABIL INC.
          FIGURE 10 SUPPLY-SIDE ANALYSIS: IVD CONTRACT MANUFACTURING MARKET (2022)
          FIGURE 11 DEMAND-SIDE ESTIMATION FOR IVD CONTRACT MANUFACTURING MARKET
          FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
          FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.2.1 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION 
    2.5 STUDY ASSUMPTIONS 
    2.6 LIMITATIONS & RISK ASSESSMENT 
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
           2.6.3 RISK ASSESSMENT
                    TABLE 2 RISK ASSESSMENT: IVD CONTRACT MANUFACTURING MARKET
    2.7 RECESSION IMPACT ANALYSIS 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 15 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 17 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 18 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHICAL SNAPSHOT, 2022
4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 IVD CONTRACT MANUFACTURING MARKET OVERVIEW 
          FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN IVD TO DRIVE MARKET
    4.2 IVD CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS 
          FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.3 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING 
          FORECAST PERIOD 52
    4.4 IVD CONTRACT MANUFACTURING MARKET: REGIONAL MIX 
          FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2028
5 MARKET OVERVIEW (Page No. - 54)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 23 MARKET DYNAMICS: IVD CONTRACT MANUFACTURING MARKET
          TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growing outsourcing activity by IVD manufacturers
                    5.2.1.2 High cost of in-house IVD manufacturing
           5.2.2 RESTRAINTS
                    5.2.2.1 IP protection concerns and possibility of theft
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential of emerging economies
                                FIGURE 24 ASIA PACIFIC: HEALTHCARE EXPENDITURE, 2010–2020 (% OF GDP)
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of skilled labor
    5.3 INDUSTRY TRENDS 
           5.3.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
           5.3.2 MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING
    5.4 PORTER’S FIVE FORCES ANALYSIS 
          FIGURE 25 IVD CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS
          TABLE 4 IVD CONTRACT MANUFACTURING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.4.1 THREAT OF SUBSTITUTES
           5.4.2 BARGAINING POWER OF SUPPLIERS
           5.4.3 INTENSITY OF COMPETITIVE RIVALRY
           5.4.4 BARGAINING POWER OF BUYERS
           5.4.5 THREAT OF NEW ENTRANTS
    5.5 TARIFF AND REGULATORY LANDSCAPE 
           5.5.1 REGULATORY ANALYSIS
                    5.5.1.1 North America
                               5.5.1.1.1 US
                                              TABLE 5 US: CLASSIFICATION OF MEDICAL EQUIPMENT
                                              TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.5.1.1.2 Canada
                                              TABLE 7 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.5.1.2 Europe
                                TABLE 8 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                                FIGURE 26 EUROPE: IVDR TIMELINE
                    5.5.1.3 Asia Pacific
                               5.5.1.3.1 Japan
                                              FIGURE 27 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN
                                              TABLE 9 JAPAN: CLASSIFICATION OF IVD REAGENTS IN JAPAN
                                              TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.5.1.3.2 China
                                              TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.5.1.3.3 India
                                              FIGURE 28 INDIA: REGULATORY PROCESS FOR IVD DEVICES
                    5.5.1.4 South Korea
                                TABLE 12 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.6 KEY CONFERENCES AND EVENTS IN 2022–2023 
          TABLE 18 IVD CONTRACT MANUFACTURING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 
    5.7 PATENT ANALYSIS 
           5.7.1 PATENT PUBLICATION TRENDS FOR IVD DEVICES
                    FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2013–JULY 2023)
           5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR IVD DEVICES PATENTS (JANUARY 2013–JULY 2023)
                    FIGURE 31 TOP 10 APPLICANT COUNTRIES/REGIONS FOR IVD DEVICES PATENTS (JANUARY 2013–JULY 2023)
           5.7.3 PATENT PUBLICATION TRENDS FOR IVD DEVICES
                    TABLE 19 IVD DEVICES: LIST OF MAJOR PATENTS
    5.8 TECHNOLOGY ANALYSIS 
           5.8.1 KEY TECHNOLOGIES: IVD CONTRACT MANUFACTURING MARKET
           5.8.2 ADJACENT TECHNOLOGIES
    5.9 SUPPLY CHAIN ANALYSIS 
           FIGURE 32 IVD CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2022)
    5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IVD PRODUCTS
           5.10.2 BUYING CRITERIA
                     FIGURE 34 KEY BUYING CRITERIA FOR IVD PRODUCTS
                     TABLE 20 KEY BUYING CRITERIA FOR IVD PRODUCTS
    5.11 ECOSYSTEM ANALYSIS 
           FIGURE 35 IVD CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS (2022)
    5.12 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS 
           FIGURE 36 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS
    5.13 IVD CONTRACT MANUFACTURING MARKET: RECESSION IMPACT 
6 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE (Page No. - 80)
    6.1 INTRODUCTION 
          TABLE 21 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
    6.2 CONSUMABLES 
           6.2.1 CONSUMABLES TO DOMINATE IVD CONTRACT MANUFACTURING MARKET
                    TABLE 22 IVD CONTRACT MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 EQUIPMENT 
           6.3.1 AUTOMATION, ADVANCEMENTS, AND EMPHASIS ON EFFICIENT DIAGNOSTICS TO DRIVE MARKET
                    TABLE 23 IVD CONTRACT MANUFACTURING MARKET FOR EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY (Page No. - 84)
    7.1 INTRODUCTION 
          TABLE 24 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    7.2 IMMUNOASSAYS 
    7.3 RISING PREVALENCE OF CANCER TO DRIVE GROWTH 
          TABLE 25 IVD CONTRACT MANUFACTURING MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 CLINICAL CHEMISTRY 
           7.4.1 GROWING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE DEMAND FOR CLINICAL CHEMISTRY ASSAY TESTING
                    TABLE 26 IVD CONTRACT MANUFACTURING MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 MOLECULAR DIAGNOSTICS 
           7.5.1 TECHNOLOGICAL INNOVATION IN PCR TESTING TO BOOST GROWTH
                    TABLE 27 IVD CONTRACT MANUFACTURING MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.6 HEMATOLOGY 
           7.6.1 RISING ADOPTION OF AUTOMATED HEMATOLOGY ANALYZERS TO DRIVE MARKET
                    TABLE 28 IVD CONTRACT MANUFACTURING MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.7 MICROBIOLOGY 
           7.7.1 RISING PREVALENCE OF MICROBIAL INFECTIONS TO DRIVE MARKET
                    TABLE 29 IVD CONTRACT MANUFACTURING MARKET FOR MICROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.8 COAGULATION & HEMOSTASIS 
           7.8.1 GROWING USE OF ANTICOAGULATION THERAPY IN SURGICAL PROCEDURES TO DRIVE MARKET
                    TABLE 30 IVD CONTRACT MANUFACTURING MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.9 OTHER TECHNOLOGIES 
          TABLE 31 IVD CONTRACT MANUFACTURING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
8 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE (Page No. - 93)
    8.1 INTRODUCTION 
          TABLE 32 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
    8.2 MANUFACTURING SERVICES 
           8.2.1 MANUFACTURING SERVICES TO HOLD LARGEST MARKET SHARE TILL 2028
                    TABLE 33 MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 ASSAY DEVELOPMENT 
           8.3.1 LOW-COST SETUP, EFFICIENCY, AND HIGH THROUGHPUT TO DRIVE DEMAND FOR ASSAY DEVELOPMENT
                    TABLE 34 ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 OTHER SERVICES 
          TABLE 35 OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
9 IVD CONTRACT MANUFACTURING MARKET, BY REGION (Page No. - 99)
    9.1 INTRODUCTION 
          FIGURE 37 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          TABLE 36 IVD CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.2 ASIA PACIFIC 
           9.2.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 38 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET SNAPSHOT
                    TABLE 37 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 38 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 39 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 40 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.2 CHINA
                    9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market
                                TABLE 41 CHINA: KEY MACROINDICATORS
                                TABLE 42 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 43 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 44 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.3 JAPAN
                    9.2.3.1 Universal healthcare reimbursement policies to propel market
                                TABLE 45 JAPAN: KEY MACROINDICATORS
                                TABLE 46 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 47 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 48 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.4 INDIA
                    9.2.4.1 Rising contract manufacturing capabilities to support growth
                                TABLE 49 INDIA: KEY MACROINDICATORS
                                TABLE 50 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 51 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 52 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.5 AUSTRALIA
                    9.2.5.1 Need for advanced medical and diagnostic tools to fuel growth
                                TABLE 53 AUSTRALIA: KEY MACROINDICATORS
                                TABLE 54 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 55 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 56 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.6 SOUTH KOREA
                    9.2.6.1 Rising spending on innovative IVD technologies to support market growth
                                TABLE 57 SOUTH KOREA: KEY MACROINDICATORS
                                TABLE 58 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 59 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 60 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.7 REST OF ASIA PACIFIC
                    TABLE 61 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 62 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 63 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.3 NORTH AMERICA 
           9.3.1 NORTH AMERICA: RECESSION IMPACT
                    TABLE 64 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 65 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 66 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 67 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.3.2 US
                    9.3.2.1 Increasing in-house manufacturing costs to encourage shift to contract manufacturing
                                TABLE 68 US: KEY MACROINDICATORS
                                TABLE 69 US: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 70 US: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 71 US: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.3.3 CANADA
                    9.3.3.1 Strong presence of key contract manufacturing companies to drive market
                                TABLE 72 CANADA: KEY MACROINDICATORS
                                TABLE 73 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 74 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 75 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.4 EUROPE 
           9.4.1 EUROPE: RECESSION IMPACT
                    TABLE 76 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 77 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 78 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 79 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.2 GERMANY
                    9.4.2.1 Germany to hold largest market share
                                TABLE 80 GERMANY: KEY MACROINDICATORS
                                TABLE 81 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 82 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 83 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.3 FRANCE
                    9.4.3.1 Increasing government pressure to reduce healthcare costs and budgetary constraints
                                TABLE 84 FRANCE: KEY MACROINDICATORS
                                TABLE 85 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 86 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 87 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.4 UK
                    9.4.4.1 Risng adoption of genome-based testing and increasing accessibility of IVD
                                TABLE 88 UK: KEY MACROINDICATORS
                                TABLE 89 UK: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 90 UK: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 91 UK: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.5 ITALY
                    9.4.5.1 Rising incidence of chronic illnesses to drive market
                                TABLE 92 ITALY: KEY MACROINDICATORS
                                TABLE 93 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 94 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 95 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.6 SPAIN
                    9.4.6.1 Increasing adoption of home-use medical devices to drive market
                                TABLE 96 SPAIN: KEY MACROINDICATORS
                                TABLE 97 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 98 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 99 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.7 REST OF EUROPE
                    TABLE 100 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 101 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 102 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 LATIN AMERICA: RECESSION IMPACT
                    TABLE 103 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 104 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 105 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 106 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Mexico to hold largest share of Latin American market
                                TABLE 107 MEXICO: KEY MACROINDICATORS
                                TABLE 108 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 109 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 110 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.5.3 BRAZIL
                    9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to drive market
                                TABLE 111 BRAZIL: KEY MACROINDICATORS
                                TABLE 112 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 113 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 114 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 115 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 116 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 117 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 GROWING HEALTHCARE INVESTMENTS AND INFRASTRUCTURAL IMPROVEMENTS TO DRIVE MARKET
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 118 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 119 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 120 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 147)
     10.1 OVERVIEW 
     10.2 KEY STRATEGIES ADOPTED BY PLAYERS 
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 39 TOP MARKET PLAYERS DOMINATE IVD CONTRACT MANUFACTURING MARKET
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 40 IVD CONTRACT MANUFACTURING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
     10.5 COMPANY EVALUATION MATRIX, 2022 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 41 IVD CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT (2022)
     10.6 COMPETITIVE BENCHMARKING 
             TABLE 121 OVERALL COMPANY FOOTPRINT
             TABLE 122 OMPANY FOOTPRINT ANALYSIS, BY PRODUCT TYPE
             TABLE 123 COMPANY FOOTPRINT ANALYSIS, BY SERVICE TYPE
             TABLE 124 COMPANY FOOTPRINT ANALYSIS, BY REGION
     10.7 COMPETITIVE SCENARIO 
             10.7.1 PRODUCT LAUNCHES
                        TABLE 125 PRODUCT LAUNCHES (JANUARY 2020–MAY 2023)
             10.7.2 DEALS
                        TABLE 126 DEALS (JANUARY 2020–MAY 2023)
             10.7.3 OTHER DEVELOPMENTS
                        TABLE 127 OTHER DEVELOPMENTS (JANUARY 2020–MAY 2023)

11 COMPANY PROFILES (Page No. - 159)
     11.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 JABIL INC.
                        TABLE 128 JABIL INC.: COMPANY OVERVIEW
                        FIGURE 42 JABIL INC.: COMPANY SNAPSHOT (2022)
             11.1.2 SANMINA CORPORATION
                        TABLE 129 SANMINA CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 SANMINA CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.3 TE CONNECTIVITY
                        TABLE 130 TE CONNECTIVITY: COMPANY OVERVIEW
                        FIGURE 44 TE CONNECTIVITY: COMPANY SNAPSHOT (2022)
             11.1.4 CELESTICA, INC.
                        TABLE 131 CELESTICA, INC.: COMPANY OVERVIEW
                        FIGURE 45 CELESTICA, INC.: COMPANY SNAPSHOT (2022)
             11.1.5 WEST PHARMACEUTICAL SERVICES, INC.
                        TABLE 132 WEST PHARMACEUTICALS SERVICES, INC.: COMPANY OVERVIEW
                        FIGURE 46 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022)
             11.1.6 SAVYON DIAGNOSTICS, LTD.
                        TABLE 133 SAVYON DIAGNOSTICS, LTD.: COMPANY OVERVIEW
             11.1.7 KMC SYSTEMS
                        TABLE 134 KMC SYSTEMS: COMPANY OVERVIEW
                        FIGURE 47 ELBIT SYSTEMS: COMPANY SNAPSHOT (2022)
             11.1.8 CENOGENICS CORPORATION
                        TABLE 135 CENOGENICS CORPORATION: COMPANY OVERVIEW
             11.1.9 NOVA BIOMEDICAL
                        TABLE 136 NOVA BIOMEDICAL: COMPANY OVERVIEW
             11.1.10 CONE BIOPRODUCTS
                        TABLE 137 CORE BIOPRODUCTS: COMPANY OVERVIEW
             11.1.11 INVETECH
                        TABLE 138 INVETECH: COMPANY OVERVIEW
                        FIGURE 48 FORTIVE: COMPANY SNAPSHOT (2022)
             11.1.12 AVIOQ, INC.
                        TABLE 139 AVIOQ, INC.: COMPANY OVERVIEW
             11.1.13 MERIDIAN BIOSCIENCE, INC.
                        TABLE 140 MERIDIAN BIOSCIENCE, INC.: COMPANY OVERVIEW
                        FIGURE 49 MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT (2022)
             11.1.14 KIMBALL ELECTRONICS, INC.
                        TABLE 141 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW
                        FIGURE 50 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2022)
             11.1.15 NEMERA
                        TABLE 142 NEMERA: COMPANY OVERVIEW
             11.1.16 VIANT MEDICAL HOLDINGS, INC.
                        TABLE 143 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW
             11.1.17 PHILLIPS-MEDISIZE CORPORATION
                        TABLE 144 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW
             11.1.18 NOLATO GW, INC.
                        TABLE 145 NOLATO GW, INC.: COMPANY OVERVIEW
                        FIGURE 51 NOLATO GW, INC.: COMPANY SNAPSHOT (2022)
             11.1.19 STRATEC SE
                        TABLE 146 STRATEC SE: COMPANY OVERVIEW
                        FIGURE 52 STRATEC SE: COMPANY SNAPSHOT (2022)
             11.1.20 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 147 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
                        FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
             11.1.21 FUJIREBIO
                        TABLE 148 FUJIREBIO: COMPANY OVERVIEW
                        FIGURE 54 H.U. GROUP: COMPANY SNAPSHOT (2022)
             11.1.22 BIOKIT (WERFEN)
                        TABLE 149 BIOKIT: COMPANY OVERVIEW
                        FIGURE 55 WERFEN: COMPANY SNAPSHOT (2022)
     11.2 OTHER COMPANIES 
             11.2.1 AFFINITY LIFESCIENCE
             11.2.2 SEKISUI
             11.2.3 PRESTIGE DIAGNOSTICS
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 210)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS